Transgene signs exclusive option agreement with Novartis for NSCLC therapeutic TG-4010 March 11, 2010
Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform March 10, 2010
Biotie and Pfizer to end discovery phase of development of PDE10 inhibitors for schizophrenia March 10, 2010
RSS